Top- News zum Sektor Gesundheit

 

BRUSSELS (dpa-AFX) - The U.K. stock market's benchmark index FTSE 100 climbed higher on Tuesday, led by gains in mining and pharmaceuticals sectors even as the mood remained somewhat cautious amid......

SOUTH SAN FRANCISCO (dpa-AFX) - The FDA's October decision calendar looks relatively light, with only a limited number of PDUFA dates scheduled.As we turn to October, here's a recap of some of the......

Eine Agrartechnologie aus den 1980er Jahren hält drei Impfstoffhersteller weiter vor Gericht fest. Für die Betroffenen droht ein langer Rechtsstreit mit ungleicher Risikoverteilung....

Shares of Akeso surged after British drug maker AstraZeneca moved to advance the Chinese biotech firm's flagship cancer drug, while a new deal from US giant Merck further underscored the sector's global momentum amid easing fears of US curbs. AstraZeneca on Tuesday announced a US$2 billion equity investment in Florida-headquartered Summit Therapeutics, which holds the exclusive rights to develop and commercialise Akeso's immunotherapy drug ivonescimab outside China. Summit and AstraZeneca would......

Von Fabiana Negrin Ochoa DOW JONES--Novo Nordisk hat ein Lizenzabkommen für einen von Hengrui Pharma entwickelten Adipositas-Wirkstoff unterzeichnet, das einen Wert von bis zu 2,6 Milliarden US-Dollar erreichen könnte. Der dänische Pharmakonzern wird ......

Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

More Hospitals Are Being Bought By Private Equity; Here's How It's Changing Healthcare... Authored by Lawrence Wilson and Sylvia Xu via The Epoch Times, There's a greater than one in 10 chance your hospital is owned by someone who's trying to double their money in seven years. If you live in Kentucky, your chances are one in six. In New Mexico, more than one in three. Walk into an emergency room, and there's a 40 percent chance the doctor who stitches you up works for a staffing company owned by private investors, not the hospital. At a time when less than half of Americans report being consistently able to afford healthcare, private investors are looking to hospitals and physician practices as a source of profit. Private equity firms, which invest money on behalf of pension funds, universities, sovereign wealth funds, and wealthy individuals, buy healthcare providers expecting them to produce a better return than the stock market. That may be no surprise to the 82 million Americans who ...

Investors should expect Eli Lilly & Co. to strike slightly larger deals, along the lines of its $7.8 billion acquisition of Centessa Pharmaceuticals Plc, as it casts a wide net for assets in the “white spaces” of science, Chief Executive Officer Dave Ricks said....

Das Pharmaunternehmen BioNTech schließt seine Werke in Marburg, Idar-Oberstein und Tübingen. Nach Unternehmensangaben scheiterte der geplante Verkauf der Standorte....

In der Corona-Pandemie verdiente Biontech Milliarden – damit ist es vorbei. Das Unternehmen muss sparen und baut Personal ab. Nun ist klar, dass an drei Standorten die Tore endgültig schließen....

Als Kassenpatient wartet man beim Arzt oft wochenlang. Kanzler Merz will das ändern. Wie ließe sich das System beenden? Drei Vorschläge...

Ziele - Der Pharmakonzern Roche gibt sich ambitionierte Ziele vor....

Pharma - Das Pharmaunternehmen Roche hat sich für die kommenden Jahre ehrgeizige Ziele gesetzt....

Finanzgesellschaft - HBM Healthcare Investments hat ihre Beteiligung an der Portfoliogesellschaft Adarx Pharmaceuticals im Rahmen von deren Börsengang ausgebaut....

KOBLENZ (dpa-AFX) - "Rhein-Zeitung" zu Krankenkassen-Reform:"Für Kassenpatienten mit gutem Einkommen wird es im neuen Jahr ein böses Erwachen geben: Hunderte Euro mehr müssen sie für Kranken- und Pflegeversicherung ausgeben. Warkens - sinnvolles - Konzept ......

Um den gesamten Artikel unter youtube.com zu lesen, klicken Sie bitte auf die Überschrift...

Fidelity's 25th annual estimate puts a 65-year-old's lifetime healthcare cost at $185,500, up 7.5% from 2025. See what Medicare covers and what it leaves out....

Kommt sie früher oder später? Die geplante Pflegereform wird zu einem neuen großen Streitpunkt zwischen Union und SPD. Die Pflegekassen warnen vor den Folgen eines Reformstopps....

Chinese biotech deal making is moving beyond the licensing of individual drug candidates, as the country transforms from a follower to a global innovation leader, according to analysts. The latest transaction underscores that shift. Beijing-based cancer drug developer InnoCare Pharma said on Thursday that it had entered into a strategic research collaboration and licensing agreement with US pharmaceutical giant Eli Lilly that could be worth up to US$3.35 billion. InnoCare said it would use its......

This week, Council on Foreign Relations President Michael Froman breaks down China's export machine, why twenty years of US pressure hasn't worked, and what happens next. And, can a $100 billion Micron factory transform Syracuse from a Rust Belt cautionary tale into a potential model for American reindustrialization? Plus, a bridge named for a hockey legend was meant to strengthen the supply chain between the US and Canada, but the neighbors can't agree on their trade relationship. Later, with 760,000 care aide openings expected every year in the US and a $400 billion long-term care bill, humanoid robots are an early bet on technology filling the care gap. (Source: Bloomberg)...